comprehensive
Previous article:
New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article: World's first CRISPR
Next article: World's first CRISPR
focus
hotspot
-
Weight loss drug costs may need more research, senator suggests
2025-09-28 20:49 -
A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.
2025-09-28 20:25 -
Gilead might be held responsible for not developing a drug
2025-09-28 20:07 -
A ‘polypill’ could sharply reduce cardiovascular disease in the U.S.
2025-09-28 19:36 -
Readout Newsletter: The latest at Gilead, Catalent, and the NIH
2025-09-28 19:28 -
For Medicare Advantage, Democrats want stronger protections around AI
2025-09-28 19:16